EUVIMEDEUVIMED entdecken
Crossref

Coptidis Rhizoma processed with Evodia Rutaecarpa improves the effect on ulcerative colitis by increasing intestinal energy metabolites alpha-ketoglutarate and Lactobacillus reuteri

Zhen-Ye Luo, Yin-Xia Hu, Chuan-Wei Qiu, Wei-Cong Chen, Li Li, Fei-Long Chen, Chang-Shun Liu

Phytomedicine · 2023

DOI: 10.1016/j.phymed.2023.155115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2023. Verfasst von Zhen-Ye Luo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Drugs, Chinese Herbal, Evodia, Limosilactobacillus reuteri. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China, Southern Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Evodia Rutaecarpa-processed Coptidis Rhizoma (ECR) is a traditional Chinese medicine for the treatment of ulcerative colitis (UC) in China. However, the mechanisms underlying the ECR processing are not elucidated. PURPOSE: Coptidis Rhizoma (CR) regulates the gut microbiota in the treatment of gastrointestinal diseases. This study explored the mechanism of action of ECR before and after processing in UC in view of the regulation of gut microecology. STUDY DESIGN: A preclinical experimental investigation was performed using a mouse model of UC to examine the regulatory effect of ECR and its mechanisms through gut microbiota analysis and metabolomic assays. METHODS: Mice received 4% dextran sulfate sodium to establish a UC model and treated with ECR and CR. Colonic histopathology and inflammatory changes were observed. Gut microbiota was analyzed using 16 s rRNA sequencing. Transplants of Lactobacillus reuteri were used to explore the correlation between ECR processing and the gut microbiota. The expression of mucin-2, Lgr5, and PCNA in colonic epithelial cells was measured using immunofluorescence. Wnt3a and β-catenin levels were detected by western blotting. The metabolites in the colon tissue were analyzed using a targeted energy metabolomic assay. The effect of energy metabolite α-ketoglutarate (α-KG) on L. reuteri growth and UC were verified in mice. RESULTS: ECR improved the effects on UC in mice compared to CR, including alleviating colonic injury and inflammation, and modulating gut microbiota by increasing L. reuteri level. L. reuteri dose-dependently alleviated colonic injury, increased mucin-2 level, and promoted colonic epithelial regeneration by increasing Lgr5 and PCNA expression. This was consistent with the results before and after ECR processing. L. reuteri promoted epithelial regeneration by upregulating Wnt/β-catenin pathway. Moreover, ECR increased metabolites levels (especially α-KG) to promote energy metabolism in the colon tissue compared to CR. α-KG treatment increased L. reuteri level and alleviated mucosal damage in UC mice. It promoted L. reuteri growth by increasing the energy metabolic status by enhancing α-KG dehydrogenase activity. CONCLUSION: ECR processing improves the therapeutic effects of UC via the α-KG-L. reuteri-epithelial regeneration axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeDrugs, Chinese HerbalEvodiaLimosilactobacillus reuteriColitisAnimalsMiceKetoglutaric AcidsMucin-2beta CateninProliferating Cell Nuclear AntigenColonDisease Models, AnimalDextran SulfateMice, Inbred C57BL

Stichwörter der Autor:innen

Coptidis Rhizoma processingEnergy metabolismL. reuteriUlcerative colitisgut microecologyα-KG

Substanzen

Ketoglutaric AcidsDrugs, Chinese HerbalMucin-2beta CateninProliferating Cell Nuclear AntigenDextran Sulfate

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Engineering Laboratory of Chinese…
  • Department of Gastroenterology, General Hospital of Southern Theater Command of People's Liberation Army (PLA), Guangzhou 510010, China.
  • Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • National Natural Science Foundation of China
  • Southern Medical University

Zitieren

APA

Luo, Z. Y., Hu, Y. X., Qiu, C. W., Chen, W. C., Li, L., Chen, F. L., & Liu, C. S. (2023). Coptidis Rhizoma processed with Evodia Rutaecarpa improves the effect on ulcerative colitis by increasing intestinal energy metabolites alpha-ketoglutarate and Lactobacillus reuteri. Phytomedicine. https://doi.org/10.1016/j.phymed.2023.155115

Vancouver

Luo ZY, Hu YX, Qiu CW, Chen WC, Li L, Chen FL, et al. Coptidis Rhizoma processed with Evodia Rutaecarpa improves the effect on ulcerative colitis by increasing intestinal energy metabolites alpha-ketoglutarate and Lactobacillus reuteri. Phytomedicine. 2023. doi:10.1016/j.phymed.2023.155115

BibTeX
@article{Luo2023,
  author = {Luo, Zhen-Ye and Hu, Yin-Xia and Qiu, Chuan-Wei and Chen, Wei-Cong and Li, Li and Chen, Fei-Long and Liu, Chang-Shun},
  title = {Coptidis Rhizoma processed with Evodia Rutaecarpa improves the effect on ulcerative colitis by increasing intestinal energy metabolites alpha-ketoglutarate and Lactobacillus reuteri},
  journal = {Phytomedicine},
  year = {2023},
  doi = {10.1016/j.phymed.2023.155115}
}
Kostenlos starten →